NEUP
Price
$6.80
Change
-$0.20 (-2.86%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
12.78M
SYBX
Price
$1.23
Change
+$0.03 (+2.50%)
Updated
Jun 26, 03:44 PM (EDT)
Capitalization
14.27M
Interact to see
Advertisement

NEUP vs SYBX

Header iconNEUP vs SYBX Comparison
Open Charts NEUP vs SYBXBanner chart's image
Neuphoria Therapeutics
Price$6.80
Change-$0.20 (-2.86%)
Volume$2.15K
Capitalization12.78M
Synlogic
Price$1.23
Change+$0.03 (+2.50%)
Volume$100
Capitalization14.27M
NEUP vs SYBX Comparison Chart in %
Loading...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEUP vs. SYBX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEUP is a Buy and SYBX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (NEUP: $6.80 vs. SYBX: $1.22)
Brand notoriety: NEUP and SYBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NEUP: 241% vs. SYBX: 30%
Market capitalization -- NEUP: $12.78M vs. SYBX: $14.27M
NEUP [@Biotechnology] is valued at $12.78M. SYBX’s [@Biotechnology] market capitalization is $14.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEUP’s FA Score shows that 1 FA rating(s) are green whileSYBX’s FA Score has 0 green FA rating(s).

  • NEUP’s FA Score: 1 green, 4 red.
  • SYBX’s FA Score: 0 green, 5 red.
According to our system of comparison, both NEUP and SYBX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEUP’s TA Score shows that 6 TA indicator(s) are bullish.

  • NEUP’s TA Score: 6 bullish, 4 bearish.

Price Growth

NEUP (@Biotechnology) experienced а +2.72% price change this week, while SYBX (@Biotechnology) price change was +0.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

NEUP is expected to report earnings on May 20, 2025.

SYBX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYBX($14.3M) has a higher market cap than NEUP($12.8M). SYBX has higher P/E ratio than NEUP: SYBX (5.55) vs NEUP (0.36). NEUP YTD gains are higher at: 98.251 vs. SYBX (-12.857). NEUP has higher annual earnings (EBITDA): 192K vs. SYBX (-13.66M). SYBX (17.3M) and NEUP (17M) have equal amount of cash in the bank . SYBX has less debt than NEUP: SYBX (0) vs NEUP (172K). NEUP has higher revenues than SYBX: NEUP (15.7M) vs SYBX (0).
NEUPSYBXNEUP / SYBX
Capitalization12.8M14.3M90%
EBITDA192K-13.66M-1%
Gain YTD98.251-12.857-764%
P/E Ratio0.365.557%
Revenue15.7M0-
Total Cash17M17.3M98%
Total Debt172K0-
FUNDAMENTALS RATINGS
SYBX: Fundamental Ratings
SYBX
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
39
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEUP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SACH1.100.02
+1.85%
Sachem Capital Corp
NWE51.170.37
+0.73%
NorthWestern Energy Group
PHG24.080.16
+0.67%
Koninklijke Philips NV
CATX3.62-0.19
-4.99%
Perspective Therapeutics
PHGE0.45-0.03
-6.05%
BiomX Inc

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with SYBX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
-2.86%
SYBX - NEUP
64%
Loosely correlated
+1.67%
BRNS - NEUP
50%
Loosely correlated
+4.43%
CMND - NEUP
31%
Poorly correlated
-2.03%
ENSC - NEUP
31%
Poorly correlated
+1.83%
SLNO - NEUP
27%
Poorly correlated
-2.06%
More

SYBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYBX has been loosely correlated with NEUP. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if SYBX jumps, then NEUP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYBX
1D Price
Change %
SYBX100%
+1.67%
NEUP - SYBX
64%
Loosely correlated
-2.86%
BTAI - SYBX
37%
Loosely correlated
-0.98%
SBHMY - SYBX
34%
Loosely correlated
N/A
MDGL - SYBX
31%
Poorly correlated
+7.88%
ATXS - SYBX
29%
Poorly correlated
-3.72%
More